Par Pharmaceutical Cos., Inc. (PRX) Tops Q3 EPS by 1c, Sales Miss Expectations

Go back to Par Pharmaceutical Cos., Inc. (PRX) Tops Q3 EPS by 1c, Sales Miss Expectations